RichardEhlersMD
General Surgery • League City, TXBreast, Melanoma, Surgical Oncology (Other than Breast)
Executive Medical Director and Associate Vice President, MD Anderson Houston Area Locations
Dr. Ehlers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2280 Gulf Freeway South
League City, TX 77573Phone+1 713-834-6624Fax+1 281-332-9610
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
University of Texas Medical Branch HospitalsResidency, Surgery, 1995 - 2002
University of Texas Medical Branch School of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2001 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025- American Board of Surgery Surgery
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery Start of enrollment: 2019 May 21
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 3 citationsPremastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial.Mark V Schaverien, Puneet Singh, Benjamin D Smith, Wei Qiao, Catherine L Akay
JAMA Network Open. 2024-04-01 - MD Anderson's 10-year experience with regional surgical oncology in the Houston area locations.Richard A Ehlers, Peter P W Pisters, Nancy D Perrier
Surgery. 2022-04-01 - 5 citationsPublisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, Michael A Davies, Merrick I Ross
Nature Medicine. 2018-12-01
Journal Articles
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaRichard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
